Your Oncology CRO

Millions fighting cancer are placing their hope in science. And we are with you answering that call with one purpose: to serve every patient’s fight. We, being your Oncology CRO partner, are delivering real intelligence to your table by uniting industry experts, global sites, AI-driven tech & academic leaders. Together, we support your mission of bridging the gap between effective therapies and unmet needs.

Trusted Force in Advancing Novel Therapies

Making real gains in solid tumours treatment means embracing precision medicine. With flexible clinical trial solutions across all phases, indications, and drug classes, we bring the agile approach tailored to your biotherapeutic, indication, and patient population.
Complex trial endpoints shouldn't stand between patients and life-changing therapies. As a Hemato-Oncology research specialists we have supported and witnessed notable treatment advances. We excel at evaluating novel agents and converting growing trial complexity into actionable insights through our multi-layered approach ensuring patients have access breakthroughs that truly make a difference.

Breast Cancer

Prostate Cancer

Ovarian Cancer

Icon symbolizing kidney cancer research.

Advanced Renal Cell Carcinoma

Colorectal Cancer

Pancreatic Cancer

Icon symbolizing gastrointestinal tumor research.

Gastrointestinal Stromal Tumour

Multiple Myeloma

Icon symbolizing lymphoma and the lymphatic system.

Lymphomas

Leukaemia

Immune Thrombocytopenia

Waldenström’s Macroglobulinemia

AL Amyloidosis

Speeding up the access for Next-Gen Oncology Solutions

Oncology Studies

Patients Enrolled

Sites

Years of Experience

From Pre-Clinical to Post-Marketing: Tailored Solutions for Every Stage

BA/BE Studies

Pharmacokinetic (PK)
Pharmacodynamic (PD)
Clinical endpoint studies

Centre of Exellence for Laboratory Services

Preclinical Testing
Bioprocess Development
Analytics & Characterization
Clinical Bioanalysis
Method Development and Validation

Clinical Trials

Phase I trials
Phase II – III trials
Phase IV post-market studies

A medical expert in surgical scrubs studies a brain scan, representing our CRO's extensive network of top oncologists and their expertise in complex clinical trials.

Leverage Our Extensive KOL Network for Oncology Trials of New Chemical Entities (NCEs)

Over the years, we’ve built strong, trusted relationships with top oncologists across specialties: hematologists, medical and surgical oncologists, radiation experts, and academic voices shaping the future of cancer care. We work closely with leading cancer hospitals and research centres and help you find the right investigators for your study. Whether you’re launching a first-in-human study or planning a complex multicentre trial, our network helps your NCEs land in the right hands and reach the patients who need them most.

It’s in the details! Smart Science driving precision in cancer research

AI-Driven Oncology

Proprietary data with advanced analytical capabilities for efficient trial design and execution.

Tech-Enabled Trials

Tailored platforms streamlining workflows and ensuring full visibility across research activities.

A Keen Eye for Detail and Meticulous Planning for Every Facet of Study

Site Management at with Global Reach and Local Precision

As oncology trials scale and grow more complex, sites need sharper vigilance and faster responsiveness. Global trials demand local precision, our site management solutions deploy skilled local associates stay close to the ground and manage every nuanced detail of trial operations. Working shoulder-to-shoulder with sites, we absorb the burden, ensure compliance, and help your trial scale with confidence.

Patient Recruitment and Retention

Every trial is about patients, so every decision we make should reflect their needs. From the earliest outreach to the last follow-up, our recruitment and retention strategies are built around respect, trust, and accessibility. Whether we’re working with local centres, tapping into real-world data, or designing support systems for complex conditions, our focus stays the same — make it easier for patients to say yes, and even easier for them to stay.

Expertise in adaptive trial designs and decentralized trials

As a tech-driven CRO, we harness adaptive trial design and decentralized solutions to bring flexibility, speed, and patient focus to modern clinical research. We are integrating real-time data through In-house EDC & CTMS platforms, to enable intelligent mid-trial adaptations that improve outcomes and compress timelines. At the same time, our decentralized models make participation easier and more accessible, supporting patients and sites, wherever they are.